In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Blend Labs Inc (NYSE: BLND) closed at $2.32 in the last session, down -4.13% from day before closing price of $2.42. In other words, the price has decreased by -$4.13 from its previous closing price. On the day, 1.05 million shares were traded. BLND stock price reached its highest trading level at $2.54 during the session, while it also had its lowest trading level at $2.3.
Ratios:
We take a closer look at BLND’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 20, 2023, Upgraded its rating to Overweight and sets its target price to $3.50 from $1.50 previously.
On November 14, 2022, Keefe Bruyette Upgraded its rating to Mkt Perform which previously was Underperform but kept the price unchanged to $2.25.
Keefe Bruyette Downgraded its Mkt Perform to Underperform on July 25, 2022, whereas the target price for the stock was revised from $4 to $2.75.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 24 ’24 when Ghamsari Nima sold 100,807 shares for $2.45 per share. The transaction valued at 247,340 led to the insider holds 0 shares of the business.
Jafari Amir bought 6,265 shares of BLND for $16,588 on Apr 12 ’24. The HEAD OF FINANCE AND ADMIN. now owns 402,716 shares after completing the transaction at $2.65 per share. On Mar 22 ’24, another insider, Ghamsari Nima, who serves as the HEAD OF BLEND of the company, sold 81,700 shares for $2.99 each. As a result, the insider received 244,291 and left with 34,774 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLND now has a Market Capitalization of 585403264 and an Enterprise Value of 643713728. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.73. Its current Enterprise Value per Revenue stands at 4.104 whereas that against EBITDA is -4.997.
Stock Price History:
The Beta on a monthly basis for BLND is 1.11, which has changed by 2.4375 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, BLND has reached a high of $3.40, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -14.74%, while the 200-Day Moving Average is calculated to be 20.23%.
Shares Statistics:
According to the various share statistics, BLND traded on average about 1.86M shares per day over the past 3-months and 1683280 shares per day over the past 10 days. A total of 240.26M shares are outstanding, with a floating share count of 160.13M. Insiders hold about 36.54% of the company’s shares, while institutions hold 25.95% stake in the company. Shares short for BLND as of 1713139200 were 7032554 with a Short Ratio of 3.78, compared to 1710460800 on 7244878. Therefore, it implies a Short% of Shares Outstanding of 7032554 and a Short% of Float of 3.08.
